Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FTC Rules Impax $112mn Pay-For-Delay Deal With Endo Was Illegal
Apr 02 2019
•
By
Penelope MacRae
The FTC Claims That Impax Illegally Delayed US Market Entry with Generic Opana ER In Return For A Payment • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin